Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.39 |
| ▸ | ADH1B | P00325 | 2/20 | 0.38 |
| ▸ | ADH1C | P00326 | 2/20 | 0.38 |
| ▸ | ADH1A | P07327 | 2/20 | 0.38 |
| ▸ | ADH4 | P08319 | 2/20 | 0.38 |
| ▸ | ADH7 | P40394 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 9/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6797179 | 1.00 | TSHR (0.41) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL6797613 | 1.00 | TSHR (0.41) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL6792415 | 1.00 | TSHR (0.41) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL6796097 | 1.00 | TSHR (0.41) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL5138900 | 0.98 | TSHR (0.37) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL9220588 | 0.91 | TSHR (0.44) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL276807 | 0.91 | TSHR (0.36) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL9245830 | 0.86 | TSHR (0.39) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL28358059 | 0.84 | TSHR (0.37) | TSHRGGPS1ADH1BADH1CADH1A | |
| SCHEMBL10304506 | 0.84 | TSHR (0.37) | TSHRGGPS1ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040067870-A1 | Fragrance raw materials aldehydes and pro-fragrances having a tertiary alpha carbon atom | THE PROCTER & GAMBLE COMPANY | 2004-04-08 | — | — | US | disclosed |
| EP-1171556-A1 | FRAGRANCE RAW MATERIALS ALDEHYDES AND PRO-FRAGRANCES HAVING A TERTIARY ALPHA CARBON ATOM | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000063329-A1 | FRAGRANCE RAW MATERIALS ALDEHYDES AND PRO-FRAGRANCES HAVING A TERTIARY ALPHA CARBON ATOM | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067870-A1 | Fragrance raw materials aldehydes and pro-fragrances having a tertiary alpha carbon atom | CUTA, TRPA1, HRH1 | TSHR 4138/4885GGPS1 2132/4885ADH1B 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.